Collplant Biotechnologies Stock Forward View - Simple Exponential Smoothing
| CLGN Stock | USD 0.80 0.05 6.67% |
Collplant Stock outlook is based on your current time horizon. Although Collplant Biotechnologies' naive historical forecasting may sometimes provide an important future outlook for the firm, we suggest always cross-verifying it against solid analysis of Collplant Biotechnologies' systematic risk associated with finding meaningful patterns of Collplant Biotechnologies fundamentals over time.
As of today the rsi of Collplant Biotechnologies' share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 0
Sell Peaked
Oversold | Overbought |
EPS Estimate Next Quarter (0.12) | EPS Estimate Current Year (0.75) | EPS Estimate Next Year (0.04) | Wall Street Target Price 11.56 | EPS Estimate Current Quarter 0.155 |
Using Collplant Biotechnologies hype-based prediction, you can estimate the value of Collplant Biotechnologies from the perspective of Collplant Biotechnologies response to recently generated media hype and the effects of current headlines on its competitors. We also analyze overall investor sentiment towards Collplant Biotechnologies using Collplant Biotechnologies' stock options and short interest. It helps to benchmark the overall future attitude of investors towards Collplant using crowd psychology based on the activity and movement of Collplant Biotechnologies' stock price.
Collplant Biotechnologies Implied Volatility | 1.08 |
Collplant Biotechnologies' implied volatility exposes the market's sentiment of Collplant Biotechnologies stock's possible movements over time. However, it does not forecast the overall direction of its price. In a nutshell, if Collplant Biotechnologies' implied volatility is high, the market thinks the stock has potential for high price swings in either direction. On the other hand, the low implied volatility suggests that Collplant Biotechnologies stock will not fluctuate a lot when Collplant Biotechnologies' options are near their expiration.
The Simple Exponential Smoothing forecasted value of Collplant Biotechnologies on the next trading day is expected to be 0.80 with a mean absolute deviation of 0.08 and the sum of the absolute errors of 4.78. Collplant Biotechnologies after-hype prediction price | USD 0.68 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
Collplant | Build AI portfolio with Collplant Stock |
Open Interest Against 2026-04-17 Collplant Option Contracts
Although open interest is a measure utilized in the options markets, it could be used to forecast Collplant Biotechnologies' spot prices because the number of available contracts in the market changes daily, and new contracts can be created or liquidated at will. Since open interest in Collplant Biotechnologies' options reflects these daily shifts, investors could use the patterns of these changes to develop long and short-term trading strategies for Collplant Biotechnologies stock based on available contracts left at the end of a trading day.
Please note that to derive more accurate forecasting about market movement from the current Collplant Biotechnologies' open interest, investors have to compare it to Collplant Biotechnologies' spot prices. As Ford's stock price increases, high open interest indicates that money is entering the market, and the market is strongly bullish. Conversely, if the price of Collplant Biotechnologies is decreasing and there is high open interest, that is a sign that the bearish trend will continue, and investors may react by taking short positions in Collplant. So, decreasing or low open interest during a bull market indicates that investors are becoming uncertain of the depth of the bullish trend, and a reversal in sentiment will likely follow.
Collplant Biotechnologies Additional Predictive Modules
Most predictive techniques to examine Collplant price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Collplant using various technical indicators. When you analyze Collplant charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Collplant Biotechnologies Simple Exponential Smoothing Price Forecast For the 8th of February
Given 90 days horizon, the Simple Exponential Smoothing forecasted value of Collplant Biotechnologies on the next trading day is expected to be 0.80 with a mean absolute deviation of 0.08, mean absolute percentage error of 0.02, and the sum of the absolute errors of 4.78.Please note that although there have been many attempts to predict Collplant Stock prices using its time series forecasting, we generally do not suggest using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that Collplant Biotechnologies' next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
Collplant Biotechnologies Stock Forecast Pattern
| Backtest Collplant Biotechnologies | Collplant Biotechnologies Price Prediction | Research Analysis |
Collplant Biotechnologies Forecasted Value
In the context of forecasting Collplant Biotechnologies' Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. Collplant Biotechnologies' downside and upside margins for the forecasting period are 0.01 and 9.60, respectively. We have considered Collplant Biotechnologies' daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Simple Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of Collplant Biotechnologies stock data series using in forecasting. Note that when a statistical model is used to represent Collplant Biotechnologies stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | 114.2215 |
| Bias | Arithmetic mean of the errors | 0.019 |
| MAD | Mean absolute deviation | 0.0784 |
| MAPE | Mean absolute percentage error | 0.0567 |
| SAE | Sum of the absolute errors | 4.78 |
Predictive Modules for Collplant Biotechnologies
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Collplant Biotechnologies. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Collplant Biotechnologies After-Hype Price Density Analysis
As far as predicting the price of Collplant Biotechnologies at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Collplant Biotechnologies or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Stock prices, such as prices of Collplant Biotechnologies, with the unreliable approximations that try to describe financial returns.
Next price density |
| Expected price to next headline |
Collplant Biotechnologies Estimiated After-Hype Price Volatility
In the context of predicting Collplant Biotechnologies' stock value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Collplant Biotechnologies' historical news coverage. Collplant Biotechnologies' after-hype downside and upside margins for the prediction period are 0.03 and 9.48, respectively. We have considered Collplant Biotechnologies' daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
Collplant Biotechnologies is dangerous at this time. Analysis and calculation of next after-hype price of Collplant Biotechnologies is based on 3 months time horizon.
Collplant Biotechnologies Stock Price Outlook Analysis
Have you ever been surprised when a price of a Company such as Collplant Biotechnologies is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Collplant Biotechnologies backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Stock price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Collplant Biotechnologies, there might be something going there, and it might present an excellent short sale opportunity.
| Expected Return | Period Volatility | Hype Elasticity | Related Elasticity | News Density | Related Density | Expected Hype |
0.95 | 8.80 | 0.12 | 0.01 | 8 Events / Month | 6 Events / Month | In about 8 days |
| Latest traded price | Expected after-news price | Potential return on next major news | Average after-hype volatility | |
0.80 | 0.68 | 15.00 |
|
Collplant Biotechnologies Hype Timeline
Collplant Biotechnologies is currently traded for 0.80. The entity has historical hype elasticity of -0.12, and average elasticity to hype of competition of -0.01. Collplant is forecasted to decline in value after the next headline, with the price expected to drop to 0.68. The average volatility of media hype impact on the company price is over 100%. The price decrease on the next news is expected to be -15.0%, whereas the daily expected return is currently at -0.95%. The volatility of related hype on Collplant Biotechnologies is about 110000.0%, with the expected price after the next announcement by competition of 0.79. The company has price-to-book (P/B) ratio of 1.03. Some equities with similar Price to Book (P/B) outperform the market in the long run. Collplant Biotechnologies recorded a loss per share of 1.03. The entity last dividend was issued on the 21st of November 2016. The firm had 2:3 split on the 1st of December 2016. Given the investment horizon of 90 days the next forecasted press release will be in about 8 days. Check out Historical Fundamental Analysis of Collplant Biotechnologies to cross-verify your projections.Collplant Biotechnologies Related Hype Analysis
Having access to credible news sources related to Collplant Biotechnologies' direct competition is more important than ever and may enhance your ability to predict Collplant Biotechnologies' future price movements. Getting to know how Collplant Biotechnologies' peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Collplant Biotechnologies may potentially react to the hype associated with one of its peers.
| HypeElasticity | NewsDensity | SemiDeviation | InformationRatio | PotentialUpside | ValueAt Risk | MaximumDrawdown | |||
| NRXS | Neuraxis | (0.01) | 9 per month | 3.92 | 0.14 | 7.88 | (5.86) | 38.80 | |
| ENLV | Enlivex Therapeutics | (0.03) | 7 per month | 4.42 | 0.04 | 8.57 | (8.16) | 24.21 | |
| NRSN | Neurosense Therapeutics | 0.01 | 9 per month | 0.00 | (0.02) | 12.82 | (7.48) | 34.62 | |
| XCUR | Exicure | 0.84 | 5 per month | 8.61 | 0.03 | 21.22 | (11.88) | 63.80 | |
| KLTO | Klotho Neurosciences | 0.00 | 5 per month | 0.00 | (0.17) | 10.34 | (10.00) | 29.02 | |
| CVKD | Cadrenal Therapeutics Common | (0.46) | 9 per month | 0.00 | (0.17) | 8.11 | (9.82) | 58.15 | |
| SONN | Sonnet Biotherapeutics Holdings | (0.58) | 8 per month | 0.00 | (0.02) | 19.48 | (18.21) | 69.59 | |
| RLYB | Rallybio Corp | 0.02 | 17 per month | 0.00 | (0.05) | 6.57 | (6.08) | 19.36 | |
| TAOX | TAO Synergies | 0.84 | 1 per month | 0.00 | (0.11) | 12.66 | (11.10) | 34.68 | |
| MTVA | MetaVia | (0.71) | 8 per month | 0.00 | (0.19) | 11.60 | (20.10) | 79.95 |
Other Forecasting Options for Collplant Biotechnologies
For every potential investor in Collplant, whether a beginner or expert, Collplant Biotechnologies' price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Collplant Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Collplant. Basic forecasting techniques help filter out the noise by identifying Collplant Biotechnologies' price trends.Collplant Biotechnologies Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Collplant Biotechnologies stock to make a market-neutral strategy. Peer analysis of Collplant Biotechnologies could also be used in its relative valuation, which is a method of valuing Collplant Biotechnologies by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Collplant Biotechnologies Market Strength Events
Market strength indicators help investors to evaluate how Collplant Biotechnologies stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Collplant Biotechnologies shares will generate the highest return on investment. By undertsting and applying Collplant Biotechnologies stock market strength indicators, traders can identify Collplant Biotechnologies entry and exit signals to maximize returns.
| Accumulation Distribution | 52486.45 | |||
| Daily Balance Of Power | 0.3333 | |||
| Rate Of Daily Change | 1.07 | |||
| Day Median Price | 0.76 | |||
| Day Typical Price | 0.77 | |||
| Price Action Indicator | 0.07 | |||
| Period Momentum Indicator | 0.05 |
Collplant Biotechnologies Risk Indicators
The analysis of Collplant Biotechnologies' basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Collplant Biotechnologies' investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting collplant stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 4.54 | |||
| Standard Deviation | 8.51 | |||
| Variance | 72.38 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for Collplant Biotechnologies
The number of cover stories for Collplant Biotechnologies depends on current market conditions and Collplant Biotechnologies' risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that Collplant Biotechnologies is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about Collplant Biotechnologies' long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Contributor Headline
Latest Perspective From Macroaxis
Collplant Biotechnologies Short Properties
Collplant Biotechnologies' future price predictability will typically decrease when Collplant Biotechnologies' long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of Collplant Biotechnologies often depends not only on the future outlook of the potential Collplant Biotechnologies' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Collplant Biotechnologies' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 11.5 M | |
| Cash And Short Term Investments | 11.9 M |
Check out Historical Fundamental Analysis of Collplant Biotechnologies to cross-verify your projections. To learn how to invest in Collplant Stock, please use our How to Invest in Collplant Biotechnologies guide.You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.
Will Biotechnology sector continue expanding? Could Collplant diversify its offerings? Factors like these will boost the valuation of Collplant Biotechnologies. Projected growth potential of Collplant fundamentally drives upward valuation adjustments. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Collplant Biotechnologies data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (1.03) | Revenue Per Share | Quarterly Revenue Growth 18.25 | Return On Assets | Return On Equity |
Investors evaluate Collplant Biotechnologies using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Collplant Biotechnologies' intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Collplant Biotechnologies' market price to deviate significantly from intrinsic value.
It's important to distinguish between Collplant Biotechnologies' intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Collplant Biotechnologies should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Collplant Biotechnologies' market price signifies the transaction level at which participants voluntarily complete trades.